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ABSTRACT
Post-mastectomy radiotherapy has been demonstrated
to improve locoregional control in breast cancer pa-
tients. We report a case involving a 44-year-old breast
cancer patient who presented with a solitary bone
metastasis in the area beneath the shoulder shield,
likely from a coincidental recurrence.
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1. INTRODUCTION
Post-mastectomy radiotherapy has been demonstrated
in randomized controlled trials to improve
locoregional control in breast cancer patients 1,2.
However, even after radiation treatment, 10%–30%
of patients relapse locoregionally, 60%–70% relapse
distally, and 10%–30% experience both types of re-
lapse 3.
At our centre, when radiating the breast, it is stan-
dard practice to employ a shoulder shield to protect
normal tissue. Here, we report a post-radiotherapy
case of a solitary bone metastasis in the area beneath
the shoulder shield in a breast cancer patient.
2. CASE HISTORY
A 44-year-old woman presented with a self-detected
lump in her left breast. She underwent a left modi-
fied radical mastectomy, and pathology reviewed a
4.5-cm grade II infiltrating ductal carcinoma with 9 of
16 lymph nodes involved. The tumour was progest-
erone-positive but estrogen- and HER2/neu–negative.
The metastatic work-up, including a bone scan, was
negative. The patient was treated with dose-dense
doxorubicin–cyclophosphamide/paclitaxel and with
radiation to locoregional lymphatic-bearing areas in
an adjuvant fashion. During the radiation treatment,
a shield was employed to protect the patient’s left
shoulder (Figure 1).
A rheumatologist followed the patient because
of ongoing benign sciatic pain. Because of increased
pelvic pain, a bone scan and computed tomography
(CT) scan were ordered. The imaging showed erosive
changes in the right sacroiliac joint, associated with
sclerosis of the adjacent bone—consistent with
sacroiliitis. In addition, the bone scan revealed an
increased uptake in the left shoulder (Figure 2). A CT
scan and a radiograph of that area confirmed a 2.5-cm
region of sclerosis within the left humeral head, rep-
resenting bone metastasis (Figure 3).
Under CT guidance, a biopsy of the left humeral
head was performed, and pathology confirmed meta-
static carcinoma consistent with a breast primary
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FIGURE 1 A shield was employed over the humeral head of the left
shoulder during the radiation treatment.SOLITARY BONE METASTASIS
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(Figure 4). The patient had a repeat metastatic work-
up, but showed no confirmed evidence of visceral
involvement at the time of writing. She was treated
with bisphosphonates and palliative radiotherapy for
the bone metastasis in the left shoulder.
3. DISCUSSION AND CONCLUSIONS
This unfortunate woman was at risk of distant me-
tastasis. At present, she has developed a solitary bone
metastasis in the left shoulder corresponding to the
shoulder shield in the radiation treatment.
Recurrence features in more than two thirds of
breast cancer patients treated with post-mastectomy
radiotherapy (3). Lee found that the greater the ex-
tent of axillary metastases, the higher the relapse rate.
When axillary nodes are unremarkable, 18% of pa-
FIGURE 2 A technetium methylene diphosphonate bone scan
showing increased tracer uptake in the posterior aspect of the left
humeral head. (A) Left/right anterior/posterior oblique and lateral
views. (B) Enlargement of left anterior oblique view.
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FIGURE 3 (A) Anterior/posterior radiograph of the left shoulder
demonstrates a sclerotic lesion in the humeral neck corresponding
to the abnormality on the bone scan. (B) Axial computed tomography
image of the left shoulder confirms a predominantly sclerotic
1.9-cm × 1.8-cm × 2.0-cm eccentric lesion in the posterolateral
humeral neck, in keeping with a metastatic focus.
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tients experience recurrence. Patients with 1–3 nodes
and more than 4 nodes positive relapse at rates of
24% and 69% respectively (3). Bone is the main site
of recurrence and accounts for 40%–60% of distant
metastases (3).
Metastasis to the bone is common in breast can-
cer, arising in 20%–60% of patients and in up to 70%–
85% at autopsy (4–7). More than 69% of these
patients have a solitary recurrence confined to a single
anatomic site, and 12% have multiple metastatic sites
(8). However, only 3.5% of breast cancer patients
develop long-bone metastases, and of those, 88%
experience recurrence in the femur (9). When the
humerus is involved, almost 90% of lesions arise in
the proximal (42%) and diaphyseal (47%) regions
(10). Metastases to the distal humerus are more in-
frequent, accounting for only 11% of cases (10).
The location of the metastasis in our patient was
initially a curious surprise. Did the treatment proto-
col play a part in the area of metastasis? Or was it a
coincidence that the bone lesion developed in the
exact area shielded with the intent of protecting nor-
mal tissue? Most likely, the location of recurrence is
a mere coincidence.
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FIGURE 4 (A) Bone biopsy of the humerus shows large malignant
epithelioid tumour cells growing in nests and sheets within spicules
of bone. The appearance is consistent with a breast primary. (B) The
tumour cells show strong staining for the progesterone receptor
(consistent with a breast primary) and the same reactivity as the
primary tumour.